Yinhan Guo

The similarity of pharmacokinetics, pharmacodynamics, safety, and immunogenicity between recombinant fully human anti-RANKL monoclonal antibody injection (MW032) and denosumab (Xgeva®) in healthy Chinese subjects: A single-center, randomized, double-blind, single-dose, parallel-controlled clinical s

Fan Wu, Zhitian Hu, Yujing Di, 2022, International immunopharmacology.

Combination Effects of Salvianolic Acid B with Low-Dose Celecoxib on Inhibition of Head and Neck Squamous Cell Carcinoma Growth In vitro and In vivo

W. Southerland, J. Califano, W. Sha, 2010, Cancer Prevention Research.

Salvianolic Acid B, a Potential Chemopreventive Agent, for Head and Neck Squamous Cell Cancer

Xinbin Gu, Yuan Zhao, Yinhan Guo, 2010, Journal of oncology.

Vitamin E Succinate Induces Ceramide-Mediated Apoptosis in Head and Neck Squamous Cell Carcinoma In vitro and In vivo

H. Cai, J. Califano, Xiaodong Song, 2008, Clinical Cancer Research.

Characterization and Evaluation of Key Sites in the Peptide Inhibitor of TAB1/p38α Interaction

Qingyang Wang, Jiyan Zhang, Yujun Pei, 2018, International Journal of Peptide Research and Therapeutics.

Highly efficient production of a dengue pseudoinfectious virus.

Xinbin Gu, X. Pang, Yanfei Zhou, 2014, Vaccine.

Pharmacokinetics, pharmacodynamics, safety and immunogenicity of recombinant, fully human anti-RANKL monoclonal antibody (MW031) versus denosumab in Chinese healthy subjects: a single-center, randomized, double-blind, single-dose, parallel-controlled trial

Heze Yu, Zhitian Hu, Yujing Di, 2023, Expert opinion on biological therapy.